S ilent brain infarction (SBI) is a common incidental finding on brain magnetic resonance imaging (MRI). Until recently, this finding had been considered a benign accompaniment to aging. 1 However, accumulating evidences have shown that SBI is a clinically important precursor lesion of many adverse health outcomes, including cognitive decline 2 and clinical stroke. 3 SBI includes 2 subtypes, lacunar type (silent lacunar infarction [SLI] ) and nonlacunar type. 4 Nonlacunar type is thought to result from an embolism or atherosclerotic stenosis. 5 Although there are some known risk factors for lacunar infarction, such as old age and hypertension, 6, 7 the risk of others is not yet clear.
Among other risk factors, diabetes mellitus has been recently recognized as a risk factor for symptomatic lacunar infarction, but not for SLI. 8 Meanwhile, some recent studies have suggested that metabolic syndrome is a risk factor for SLI.
University Hospital Health Promotion Center, were recruited. All the examinations were taken at the same day. Among them, 40 subjects who had reported previous stroke were excluded. Subjects with previous stroke were defined as either having reported that they had previous confirmed clinical stroke or reported taking medication for stroke in a self-completion questionnaire. Finally, 2326 subjects were included in the analysis. The study was approved by the institutional review board at Seoul National University Hospital (Institutional Review Board No 1502-026-647).
Baseline Data Collection
Clinical information, including age, sex, smoking status, comorbid conditions, and medications related to hypertension, diabetes mellitus, and dyslipidemia, were obtained by a self-completion questionnaire. In addition, the subjects who were taking aspirin, clopidogrel, warfarin, or other antiplatelet drugs were identified. Blood tests were done after 12 hours of overnight fasting to measure glucose, insulin, creatinine, and total cholesterol levels. Blood pressure was measured after resting for >5 minutes in the sitting position. Subjects were considered to have hypertension if they had a high systolic (≥140 mm Hg) or diastolic (≥90 mm Hg) blood pressure 16 or were currently taking antihypertensive medications. Subjects with a total cholesterol level of ≥240 mg/dL or currently taking lipid-lowering agents were considered to have hypercholesterolemia. 17 Diabetes mellitus was defined as hemoglobin A1c ≥6.5%, fasting glucose ≥126 mg/dL, 18 or being on diabetes mellitus medication. Kidney function was estimated from the Modification of Diet in Renal Disease (MDRD) formula, which was staged according to the chronic kidney disease categorization of the US National Kidney Foundation, as normal (≥90) renal function or mild (60-89.9), moderate (30-59.9), and severe (<30 mL/min per 1.73 m 2 ) renal dysfunction. 19 The body mass index (BMI) was calculated as weight (kg) divided by the height squared (m 2 ). Overweight (BMI, 23.0-24.9) and obesity (BMI ≥25.0) were defined according to the World Health Organization criteria for the Asia-Pacific region.
20

Definition of IR
IR was estimated using the homeostasis model assessment-estimated insulin resistance (HOMA-IR) index, which is widely used for the estimation of IR in clinical and epidemiological research. 21, 22 HOMA-IR was calculated by multiplying glucose (mg/dL) by insulin (µU/mL) and dividing by 405. 23 The cutoff value of 2.56 was used to diagnose for IR, as previously reported in Korean adults. 24 In addition, we used the HOMA-IR criteria from the Japan Diabetes Society, 25, 26 in which HOMA-IR ≤1.60 indicates non-IR and HOMA-IR ≥2.50 is regarded as IR, as another representative criteria in Eastern Asia.
Diagnosis of SLI
SLI was defined as a focal infarction, which was 0.3 to 1.5 cm in diameter and in the territory of perforating branches to the basal ganglia, thalamus, internal capsule, corona radiate, centrum semiovale, brain stem, or cerebellum, that had central signal intensity corresponding to the cerebrospinal fluid on T1-and T2-weighted images in MRI examinations. Lesions were differentiated on fluid-attenuated inversion recovery from periventricular white matter lesions, which were of high signal intensity. Dilated perivascular spaces were distinguished from SLI based on their locations (along perforating or medullary arteries, often bilaterally symmetrical, usually in the lower third of the basal ganglia) and by the absence of gliosis. The MRI were independently evaluated by 2 neurologists (J.-S.L. and H.-M.K.). MRI was performed at 1.5-T field strength (Signa, GE Healthcare, Milwaukee, WI, or Magnetom SONATA, Siemens, Munich, Germany). The imaging protocol consisted of T2-weighted fast spin-echo (repetition time/ echo time=5000/127 ms), T1-weighted spin-echo (repetition time/ echo time=500/11 ms), and fluid-attenuated inversion recovery imaging (repetition time/echotime=8800/127 ms; inversion time=2250 ms). Images were obtained as 26 transaxial slices per scan. The slice thickness was 5 mm, with a 1-mm interslice gap. In addition, the volume of white matter hyperintensity (WMH) was assessed. The MRI from January 2006 to December 2011 (n=1671) were reviewed by 1 reader (H.-Y.J.), who was blinded to clinical data. Scans were converted from DICOM to Analyze format, using MRIcro software (University of Nottingham School of Psychology, Nottingham, United Kingdom; http://www.mricro.com), for computer-assisted determination of WMH volume. 27 Signal intensity thresholding, followed by manual editing, was used to create a region-of-interest map of supratentorial WMHs. Axial T2-fluid-attenuated inversion recovery sequences were used to create the WMH maps.
Statistics
Data were summarized as numbers with percentages for categorical variables and mean values with standard deviation for continuous variables. For each demographic and clinical feature by the SLI status, we performed a group-wise comparison using the Student t test for continuous variables and the χ 2 test for categorical variables (Table 1 ). Univariate logistic regression was used to evaluate the association of each variable and presence of SLI ( Table 2 ). For multivariate analysis, we included the following risk factors that were considered in previous studies, 6, 7 namely, age, sex, hypertension, hypercholesterolemia, diabetes mellitus, smoking, BMI, chronic kidney disease, medications that might affect IR or SLI, antidiabetic and antiplatelet medication, and C-reactive protein. Three models were defined for multivariate analyses. Model 1 divided subjects according to antidiabetic medication and adjusted for it. Model 2 divided subjects according to diabetes mellitus status. Model 3 excluded subjects with diabetes mellitus. These models were applied to all multivariate analyses of this study. We used ordered logistic regression to assess the association between IR and the increasing number of SLI lesions (Table 3) . When the dependent variable is ordinal, this statistical method gives cumulative probabilities as odds ratios. 28 In this model, the dependent variable has multiple cutoff levels (eg, SLI lesion 1, ≥2 versus 0 and ≥ 2versus 0, 1). A single equation is estimated over the levels of the dependent variable, and a cumulative odds ratio is calculated from the equation. It is assumed that the odds ratios of each cutoff level are about the same with the calculated odds ratio (proportional odds assumption). In addition, the proportions of subjects with each number of SLI lesions 1, ≥2, and a total by IR groups were compared by χ 2 test (Figure) . Linear regression was applied to evaluate the association between each variable and the volume of WMH (Table I in the online-only Data Supplement). In addition, multivariate logistic regression, using another HOMA-IR cutoff level by the Japan Diabetes Society criteria, was conducted (Table II in the online-only Data Supplement). The association between continuous HOMA-IR level and presence of SLI was also analyzed by multivariate logistic regression (Table  III in 
Results
Study Population Characteristics
Among the total 2326 subjects who were included in the analysis, 18.1% showed IR (HOMA-IR≥2.56). The proportion of subjects with IR was higher in the group that had SLI than that in the group without SLI (27.7% versus 17.3%; P<0.001). And the mean level of HOMA-IR was also higher in SLI (+) group than in SLI (−) group (2.1 versus 1.7; P=0.002). Fasting glucose and fasting insulin levels were also higher in the SLI (+) group. As for age distribution, the mean age was significantly higher in the SLI (+) group than in the SLI (−) group (62.2 versus 55.6; P<0.001). The proportions of hypertension, diabetes mellitus, and chronic kidney disease were higher in the SLI (+) group than in the SLI (−) group (all P<0.01). The distribution of other cardiovascular risk factors and medications did not show significant differences between the 2 groups (Table 1) .
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December 2016 Table 2 ). When the Japanese criteria were applied, the same association between IR and SLI was observed in all the 3 models (model 1; aOR, 1.78; 95% CI, 1.19-2.66; P=0.005; and aOR, 1.20; 95% CI, 0.82-1.77; P=0.353 for HOMA-IR ≥2.50 and >1.60, <2.50, respectively; Table II in the online-only Data Supplement). In a multivariate logistic analysis using continuous HOMA-IR level, the same positive association was observed (model 1; aOR, 1.57; 95% CI, 1.10-2.24; P=0.014; Table III in the online-only Data Supplement).
Association Between IR and Presence of SLI
Association Between IR and Multiple SLI
When compared with subjects without IR, subjects with IR showed a higher prevalence of one SLI lesion (8.1% versus 5.5%) and multiple SLI lesions (4.3% versus 1.7%). The association was statistically significant in a χ 2 test (P<0.001; Figure) .
Association Between IR and Increasing Number of SLI
We assessed the association between IR and the increasing number of SLI using ordered logistic regression. In a univariate analysis, when 1 unit of IR increased (<2.56 to ≥2.56), odds ratios for the presence of SLI (1, ≥2 versus 0) and for 2 Among the other covariates, in the multivariate models, age and hypertension showed a positive association with the volume of WMH, whereas BMI was negatively associated (Table  I in the online-only Data Supplement).
Discussion
In this study, we investigated the association between IR and SLI using detailed demographic, lifestyle, clinical, and medication factors in screened Korean adults. We found that IR was independently associated with both the presence and the severity of SLI using an appropriate multivariate analysis adjusted for known SLI-related risk factors.
Until now, there have been some studies on associations of traditional cardiovascular risk factors constituting metabolic syndrome and metabolic syndrome itself and SLI. 9, 10 However, there has been lack of research on the association of IR and SLI. A recent study demonstrated that thiazolidinedione, whose main mechanism is the reduction of IR, decreased the risk of stroke recurrence. 13 This result implied that IR may be a risk factor in the development of SLI. Another recent study with 934 participants from the Atherosclerosis Risk in Communities (ARIC) study, who completed 2 brain MRI with a 10-year interval, reported positive association between IR and new lacunar lesions. 12 Although it used study populationspecific IR score as an IR estimation index, it first investigated prospectively the relationship of IR and future occurrence of lacunar infarction and demonstrated possible causal relationship between IR and lacunar infarction. In addition to above study findings, our findings give strong additional evidence to the association between IR and lacunar lesions.
IR is a hallmark of many cardiovascular diseases. 29, 30 IR causes type 2 diabetes mellitus; however, it is also a fundamental mechanism for metabolic syndrome and its components, namely, hypertension and hypercholesterolemia. 29, 30 In this study, we analyzed the association of IR and SLI using 3 models: adjusting for antidiabetic medication, adjusting for diabetes mellitus, and after the exclusion of diabetes mellitus patients. IR was associated with the presence and severity of SLI in all the 3 models. This implies that IR is a risk factor of SLI, irrespective of diabetes mellitus and other cardiovascular risk factors.
It is still unclear whether the pathophysiology of SLI is different from cortical ischemic stroke and is a point that is currently under debate. 5, 7 Nonetheless, SLI can be attributed to 2 main pathological mechanisms: atherosclerosis and endothelial dysfunction.
Atherosclerosis has been observed as a pathological feature of SLI. 31 Early studies including postpartum specimens aOR indicates adjusted odds ratio; CI, confidence interval; HOMA-IR, homeostasis model assessment-estimated insulin resistance; OR, odds ratio; and SLI, silent lacunar infarction.
*ORs and P values were calculated using ordered logistic regression for 3 ordered categories according to number of SLI (0, 1, and ≥ 2). Models 1-3 are multivariate analysis models including each of the following variables: model 1: HOMA-IR, age, sex, hypertension, hypercholesterolemia, smoking, body mass index, chronic kidney disease stage, antidiabetic medication, anticoagulation or antiplatelet medication, and C-reactive protein; model 2: HOMA-IR, age, sex, hypertension, hypercholesterolemia, diabetes mellitus, smoking, body mass index, chronic kidney disease stage, anticoagulation or antiplatelet medication, and C-reactive protein; model 3: HOMA-IR, age, sex, hypertension, hypercholesterolemia, smoking, body mass index, chronic kidney disease stage, anticoagulation or antiplatelet medication, and C-reactive protein. Diabetes mellitus patients were excluded in model 3.
†Those who were taking antihypertensive drugs or SBP ≥140 mm Hg or DBP ≥90 mm Hg. ‡Those who were taking lipid-lowering drugs or total cholesterol ≥240 mg/dL. §Those who were taking antidiabetic medications or hemoglobin A1c ≥6.5% or fasting glucose ≥126 mg/dL. ‖Current smokers.
¶Normal: stage 1, mild: stage 2, moderate to severe: stages 3, 4, and 5 by chronic kidney disease stages of the US National Kidney Foundation. #Those who were taking aspirin, clopidogrel, warfarin, or other antiplatelet medication.
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showed focal atheromas and atheromatous stenosis associated with SLI lesions. Also, many typical vascular risk factors that are known to be associated with atherosclerosis contribute to the development of SLI. 32 Recently, many cellular and molecular studies have provided detailed rationales for the association between IR and atherosclerosis. 29, 33 First, IR is associated with elevated levels of inflammatory markers. This proinflammatory condition is also related to atherosclerosis. Second, IR may disturb some signaling pathways, making them proatherogenic. For instance, the mitogen-activated protein kinase signaling pathway is enhanced in IR condition, which may contribute to atherosclerosis with an increase in cell adhesion and interactions. Thus, IR may aggravate atherosclerosis in varied ways, contributing to the development of SLI.
However, it was recently proposed that endothelial dysfunction is also a key process in the development of SLI. This hypothesis is supported by the observation that the arteriolar wall appeared thickened as it passed through the lacunar infarction lesion, not proximal to it. 31 It is regarded that the activation of the cerebral microvascular endothelium might be the primary step in the pathogenesis of SLI, subsequently leading to increased permeability of the blood-brain barrier. 34, 35 IR is also suggested to be related to endothelial dysfunction. Both IR and endothelial dysfunction are commonly observed in many cardiovascular diseases. 36, 37 The link between IR and endothelial dysfunction is explained by some molecular and cellular mechanisms. IR increases lipolysis and induces proinflammatory cytokines. Such lipotoxicity and inflammation may contribute to endothelial dysfunction, explaining the link between IR and endothelial dysfunction. 36, 37 Thus, IR may lead to the development of SLI, via both endothelial dysfunction and atherosclerosis. In this study, we investigated the association of C-reactive protein, which is one of known inflammatory marker associated with both atherosclerosis 38 and endothelial dysfuntion, 39 with SLI. However, it did not show a significant association with the presence and severity of SLI. Nonetheless, because C-reactive protein is only one nonspecific inflammatory parameter, among numerous atherosclerosis and endothelial dysfunction development-related markers, 40 the hypothesis linking IR-induced atherosclerosis and endothelial dysfunction to SLI development is still valid and should be evaluated in a separate, well-designed trial.
In addition, we assessed the association of IR and the volume of WMH. WMH is strongly associated with the risk of stroke 41 ; however, its pathogenesis and risk factors are not well-known. 41 In this study, IR did not show significant association with the volume of WMH. However, aging and hypertension were positively associated with WMH, and BMI showed a negative association. This result implied that WMH has different risk factors from lacunar infarction, which is consistent with a recent study. 12 This study has some limitations. First, as a cross-sectional study, this study cannot convince the causal relationship between IR and SLI. It is possible that IR is just associated with endothelial dysfunction or atherosclerosis and does not have causal effect on SLI. Second, we estimated IR by the HOMA-IR index, not by the euglycemic hyperinsulinemic clamp method, which is the gold standard for IR measurement. However, the clamp method is cumbersome and unsuitable for large studies. HOMA-IR is a commonly used alternative method in clinical and epidemiological studies. Third, because the cutoff level of HOMA-IR is influenced by race, age, and disease, it is not uniform. We tried to apply the appropriate cutoff level for the participants in this study, by using the HOMA-IR cutoff level from a study with healthy Korean population. In addition, we performed a further analysis using the Japan criteria with a similar ethnic background, which showed the same significant results. Fourth, antidiabetic medication was not assessed by different categories, which could influence IR differently. Fifth, this study does not provide functional or cognitive correlations.
Conclusions
In conclusion, IR was independently associated with both the presence and the severity of SLI. A longitudinal study of the causality and an interventional trial seeing whether IR improvement might lead to prevention of SLI should be followed.
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